grepcent public filings, reorganized for comparison

DIVERSIFIED HEALTHCARE TRUST (DHC)

CIK: 0001075415. SIC: 6798 Real Estate Investment Trusts. Latest 10-K as of: 2026-02-24.

SIC breadcrumb: Finance, Insurance, And Real Estate > Holding And Other Investment Offices > SIC 6798 Real Estate Investment Trusts

SEC company page: https://www.sec.gov/edgar/browse/?CIK=1075415. Latest filing source: 0001075415-26-000013.

Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.

At a glance

FY2025 · period end 2025-12-31 · filed 2026-02-24 · accession 0001075415-26-000013 · source: SEC companyfacts

Revenue
1,537,853,000 USD verified
Net income
-285,886,000 USD verified
Assets
4,361,250,000 USD verified
Free cash flow
-166,441,000 USD computed
Net margin
-18.59% computed
Revenue YoY
+2.84% computed
ROE
-17.16% computed

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

Peer & cluster context

Peer percentile fingerprint

DHC ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 6798; per-ratio N printed.DHC ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 6798; per-ratio N printed.RatioDHCPeer medianPercentileNNet margin-18.6%16.8%9149Revenue growth2.8%3.7%46149FCF margin-10.8%21.8%770ROE-17.2%5.7%4151ROA-6.6%1.5%2155Liabilities / equity1.621.4856151

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC industry 6798 Real Estate Investment Trusts, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

Selected Fundamentals

MetricValueUnitFYFiled
Revenue1,537,853,000USD20252026-02-24
Net income-285,886,000USD20252026-02-24
Assets4,361,250,000USD20252026-02-24

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-24. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001075415.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric2008200920102016201720182019202020212022202320242025
Revenue1,058,022,0001,074,729,0001,117,164,0001,040,155,0001,632,026,0001,383,212,0001,283,566,0001,410,308,0001,495,427,0001,537,853,000
Net income141,295,000147,610,000286,872,000-88,234,000-139,453,000174,515,000-15,774,000-293,572,000-370,255,000-285,886,000
Diluted EPS1.010.900.91-0.37-0.590.73-0.07-1.23-1.55-1.19
Operating cash flow424,481,000419,304,000392,840,000265,845,000158,544,000-63,323,000-40,353,00010,483,000112,223,000-19,618,000
Capital expenditures99,663,000117,213,000103,804,000222,417,000185,585,000227,605,000299,387,000235,007,000201,702,000146,823,000
Dividends paid370,489,000370,608,000370,746,000199,719,00042,825,0009,540,0009,568,0009,595,0009,627,0009,661,000
Share buybacks452,000341,000411,000299,000171,000383,000171,000393,000904,0001,145,000
Assets7,227,754,0007,294,019,0007,160,426,0006,653,826,0006,476,424,0006,623,514,0006,002,093,0005,446,136,0005,137,005,0004,361,250,000
Liabilities4,028,349,0004,016,831,0003,980,556,0003,776,776,0003,857,202,0003,961,124,0003,363,482,0003,109,245,0003,178,162,0002,695,682,000
Stockholders' equity3,199,405,0003,104,950,0003,023,112,0002,736,519,0002,495,837,0002,662,390,0002,638,611,0002,336,891,0001,958,843,0001,665,568,000
Cash and cash equivalents31,749,00031,238,00054,976,00037,357,00074,417,000634,848,000658,065,000245,939,000144,584,000105,407,000
Free cash flow324,818,000302,091,000289,036,00043,428,000-27,041,000-290,928,000-339,740,000-224,524,000-89,479,000-166,441,000

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric2008200920102016201720182019202020212022202320242025
Net margin13.35%13.73%25.68%-8.48%-8.54%12.62%-1.23%-20.82%-24.76%-18.59%
Return on equity4.42%4.75%9.49%-3.22%-5.59%6.55%-0.60%-12.56%-18.90%-17.16%
Return on assets1.95%2.02%4.01%-1.33%-2.15%2.63%-0.26%-5.39%-7.21%-6.56%
Liabilities / equity1.261.291.321.381.551.491.271.331.621.62

Industry Peer Context

Each number-line places DHC against the min, median, and max of latest reported values among companies in the same SIC industry when at least three peers report that ratio.

Net margin peer context

DHC Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6798; peer count 149.DHC Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6798; peer count 149.149 SIC peersMin -122.2%Median 16.8%Max 143.8%DHC -18.6%

ROE peer context

DHC ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6798; peer count 151.DHC ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6798; peer count 151.151 SIC peersMin -49.4%Median 5.7%Max 103.0%DHC -17.2%

ROA peer context

DHC ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6798; peer count 155.DHC ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6798; peer count 155.155 SIC peersMin -34.4%Median 1.5%Max 42.5%DHC -6.6%

Financial Bridges

Waterfall figures reconcile reported SEC companyfacts components. Missing bridges are omitted when required components are not present for the same fiscal year.

Free cash flow = operating cash flow - capital expenditures

DHC FY2025 free cash flow bridge from reported figures.DHC FY2025 free cash flow bridge from reported figures.DHC free cash flow bridgeFY2025: operating cash flow less capital expendituresSource: SEC companyfacts FY2025.Free cash flow bridgeReported amount-$250.0M$0.0B$250.0M-$19.6MOperating cash flow-$146.8MCapex-$166.4MFree cash flow

Figure provenance: SEC companyfacts FY 2025. Operating cash flow: accession 0001075415-26-000013; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0001075415-26-000013; concept PaymentsForCapitalImprovements; source concepts us-gaap:PaymentsForCapitalImprovements | Free cash flow: accession 0001075415-26-000013; concept NetCashProvidedByUsedInOperatingActivities - PaymentsForCapitalImprovements; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsForCapitalImprovements

Financial Charts

DHC revenue, last 5 periods. Source: SEC companyfacts FY2025.DHC revenue, last 5 periods. Source: SEC companyfacts FY2025.DHC RevenueLatest point: FY2025 = $1.5BSource: SEC companyfacts FY2025.Fiscal yearReported revenue$0.0B$1.0B$2.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001075415-26-000013; filed 2026-02-24. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

DHC net income, last 5 periods. Source: SEC companyfacts FY2025.DHC net income, last 5 periods. Source: SEC companyfacts FY2025.DHC Net incomeLatest point: FY2025 = -$285.9MSource: SEC companyfacts FY2025.Fiscal yearNet income-$500.0M$0.0B$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001075415-26-000013; filed 2026-02-24. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

DHC diluted eps, last 5 periods. Source: SEC companyfacts FY2025.DHC diluted eps, last 5 periods. Source: SEC companyfacts FY2025.DHC Diluted EPSLatest point: FY2025 = -$1.19/shareSource: SEC companyfacts FY2025.Fiscal yearDiluted EPS (USD/share)-$2.00/share$0.00/share$1.50/shareFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001075415-26-000013; filed 2026-02-24. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

DHC operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.DHC operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.DHC Operating cash flowLatest point: FY2025 = -$19.6MSource: SEC companyfacts FY2025.Fiscal yearOperating cash flow-$250.0M$0.0B$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001075415-26-000013; filed 2026-02-24. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

DHC capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.DHC capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.DHC Capital expendituresLatest point: FY2025 = $146.8MSource: SEC companyfacts FY2025.Fiscal yearCapital expenditures$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001075415-26-000013; filed 2026-02-24. Concept: PaymentsForCapitalImprovements. Source concepts: us-gaap:PaymentsForCapitalImprovements.

DHC dividends paid, last 5 periods. Source: SEC companyfacts FY2025.DHC dividends paid, last 5 periods. Source: SEC companyfacts FY2025.DHC Dividends paidLatest point: FY2025 = $9.7MSource: SEC companyfacts FY2025.Fiscal yearDividends paid$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001075415-26-000013; filed 2026-02-24. Concept: PaymentsOfDividendsCommonStock. Source concepts: us-gaap:PaymentsOfDividendsCommonStock.

DHC share buybacks, last 5 periods. Source: SEC companyfacts FY2025.DHC share buybacks, last 5 periods. Source: SEC companyfacts FY2025.DHC Share buybacksLatest point: FY2025 = $1.1MSource: SEC companyfacts FY2025.Fiscal yearShare buybacks$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001075415-26-000013; filed 2026-02-24. Concept: PaymentsForRepurchaseOfCommonStock. Source concepts: us-gaap:PaymentsForRepurchaseOfCommonStock.

DHC assets, last 5 periods. Source: SEC companyfacts FY2025.DHC assets, last 5 periods. Source: SEC companyfacts FY2025.DHC AssetsLatest point: FY2025 = $4.4BSource: SEC companyfacts FY2025.Fiscal yearAssets$0.0B$4.0B$8.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001075415-26-000013; filed 2026-02-24. Concept: Assets. Source concepts: us-gaap:Assets.

DHC liabilities, last 5 periods. Source: SEC companyfacts FY2025.DHC liabilities, last 5 periods. Source: SEC companyfacts FY2025.DHC LiabilitiesLatest point: FY2025 = $2.7BSource: SEC companyfacts FY2025.Fiscal yearLiabilities$0.0B$2.0B$4.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001075415-26-000013; filed 2026-02-24. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

DHC stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.DHC stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.DHC Stockholders' equityLatest point: FY2025 = $1.7BSource: SEC companyfacts FY2025.Fiscal yearStockholders' equity$0.0B$2.0B$4.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001075415-26-000013; filed 2026-02-24. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

DHC cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.DHC cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.DHC Cash and cash equivalentsLatest point: FY2025 = $105.4MSource: SEC companyfacts FY2025.Fiscal yearCash and cash equivalents$0.0B$375.0M$750.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001075415-26-000013; filed 2026-02-24. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.

DHC free cash flow, last 5 periods. Source: SEC companyfacts FY2025.DHC free cash flow, last 5 periods. Source: SEC companyfacts FY2025.DHC Free cash flowLatest point: FY2025 = -$166.4MSource: SEC companyfacts FY2025.Fiscal yearFree cash flow-$500.0M-$250.0M$0.0BFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001075415-26-000013; filed 2026-02-24. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsForCapitalImprovements. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsForCapitalImprovements.

As-reported value updates

1 tracked difference above grepcent's stated thresholds were found between the earliest XBRL-filed value and the value currently on file for the same fiscal period.

View the filing-by-filing ledger →

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-03. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001075415.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2022-Q32022-09-30-0.34reported discrete quarter
2023-Q12023-03-31-0.22reported discrete quarter
2023-Q22023-06-30-0.30reported discrete quarter
2023-Q32023-09-30356,524,000-65,779,000-0.28reported discrete quarter
2023-Q42023-12-31361,535,000-102,564,000derived Q4 = FY annual - nine-month YTD
2024-Q12024-03-31370,776,000-86,259,000-0.36reported discrete quarter
2024-Q22024-03-31-86,259,000reported discrete quarter
2024-Q22024-06-30371,392,000-0.41reported discrete quarter
2024-Q32024-06-30-97,861,000reported discrete quarter
2024-Q32024-09-30373,640,000-0.41reported discrete quarter
2024-Q42024-12-31379,619,000-87,446,000derived Q4 = FY annual - nine-month YTD
2025-Q12025-03-31386,864,000-8,986,000-0.04reported discrete quarter
2025-Q22025-03-31-8,986,000reported discrete quarter
2025-Q22025-06-30382,712,000-0.38reported discrete quarter
2025-Q32025-06-30-91,639,000reported discrete quarter
2025-Q32025-09-30388,706,000-0.68reported discrete quarter
2025-Q42025-12-31379,571,000-21,221,000derived Q4 = FY annual - nine-month YTD
2026-Q12026-03-31366,471,000-43,275,000-0.18reported discrete quarter
2026-Q22026-03-31-43,275,000reported discrete quarter
2026-Q22026-06-30365,387,000-0.16reported discrete quarter

Quarterly Charts

DHC quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q2.DHC quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q2.DHC Quarterly RevenueLatest point: 2026-Q2 = $365.4MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Revenue$0.0B$250.0M$500.0M2023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001075415-26-000030; filed 2026-08-03. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

DHC quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q2.DHC quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q2.DHC Quarterly Net incomeLatest point: 2026-Q2 = -$43.3MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Net income-$250.0M-$125.0M$0.0B2023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001075415-26-000024; filed 2026-05-04. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

DHC quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q2.DHC quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q2.DHC Quarterly Diluted EPSLatest point: 2026-Q2 = -$0.16/shareSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Diluted EPS (USD/share)-$1.00/share-$0.50/share$0.00/share2022-Q32023-Q12023-Q22023-Q32024-Q12024-Q22024-Q32025-Q12025-Q22025-Q32026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001075415-26-000030; filed 2026-08-03. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Business

Read DHC's verbatim Item 1 Business section from its latest 10-K: Business.

Risk Factors

Read DHC's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.

Latest quarter (10-Q)

Latest 10-Q source: 0001075415-26-000030.

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Confidence: high. Filing date: 2026-08-03. Report date: 2026-06-30.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion should be read in conjunction with our condensed consolidated financial statements and notes thereto included in this Quarterly Report on Form 10-Q and with our Annual Report.

OVERVIEW

We are a REIT organized under Maryland law that primarily owns senior living communities, medical office and life science properties and other healthcare related properties throughout the United States. As of June 30, 2026, we owned 285 properties located in 33 states and Washington, D.C. As of June 30, 2026, we owned an equity interest in each of the Seaport JV and the LSMD JV that own medical office and life science properties located in five states with an aggregate of approximately 2.2 million rentable square feet that were 99% leased with an average (by annualized rental income) remaining lease term of 13.6 years.

We are encouraged by positive trends, including increases in rates, margins and occupancy in our SHOP segment. Additionally, we expect that favorable supply and demand dynamics in the senior living industry will enable our managers to continue to grow occupancy and drive positive performance. While certain costs, primarily labor, insurance and food costs, have increased, we expect these cost increases to moderate, which will provide our managers the opportunity to increase revenue in excess of increases in costs, resulting in improving returns to us.

In an effort to optimize performance, our asset management team reviews the results of each of our senior living communities and our operators, taking into account various factors such as performance metric benchmarks, location and other relevant data points. This comprehensive review process ensures that our decisions are data-driven and strategically aligned with our overall objectives. As a result of these reviews, our strategy to drive positive performance includes analyzing non-performing communities for potential disposition or transition to different operators.

We are closely monitoring the impacts of the current economic and market conditions on all aspects of our business, including, but not limited to, uncertainties surrounding interest rates and inflation, volatility in the public debt and equity markets, global geopolitical hostilities and tensions, any U.S. government shutdown, economic uncertainties and tariffs, labor market conditions and changes in real estate utilization. We expect to experience continued variability in labor, insurance and food costs in our SHOP segment. Inflationary pressures in the United States, as well as global geopolitical instability and tensions, have given rise to uncertainty regarding potential disruptions in the financial markets. Continued or intensified disruptions in the financial markets could adversely affect our financial condition and that of our managers, operators and tenants, could adversely impact the ability or willingness of our managers, operators, tenants or residents to pay amounts owed to us, could impair our ability to effectively deploy our capital or realize our target returns on our investments, may restrict our access to, and would likely increase, our cost of capital, and may cause the values of our properties and of our securities to decline.

For further information and risks relating to these economic uncertainties and their impact on our business and financial condition, see Part I, Item 1, "Business" and Part I, Item 1A, "Risk Factors" in our Annual Report.

Portfolio Overview (dollars in thousands, except average monthly rate and per square foot amounts)

The following table presents an overview of our portfolio as of and for the three months ended June 30, 2026:

Gross
Number of UnitsBook Value
Number oforof Real Estate
PropertiesSquare FeetAssets (1)NOI (2)% of NOI (2)
SHOP19922,469units$4,409,401$53,49563.4%
Medical Office and Life Science Portfolio675,558,089sq. ft.1,489,55723,70928.1%
Triple net leased senior living communities91,328units155,1623,4464.1%
Wellness centers10812,246sq. ft.208,1103,7934.4%
Total285$6,262,230$84,443100.0%

(1)Represents gross book value of real estate assets at cost plus certain acquisition costs, before depreciation and purchase price allocations and less impairment write downs, if any.

(2)We calculate our net operating income, or NOI, on a consolidated basis and by reportable segment. Our definition of NOI and our reconciliation of net income (loss) to NOI are included below under the heading “Non-GAAP Financial Measures.”

21

Table of Contents

The following tables present key operating metrics of our portfolio as of and for the three and six months ended June 30, 2026 and 2025:

Comparable Properties (1)All Properties
As of and for theAs of and for the
Three Months Ended June 30,Three Months Ended June 30,
2026202520262025
SHOP
Total properties184184199230
Number of units21,12421,12422,46924,872
Occupancy83.1%81.5%82.5%80.6%
Average monthly rate (2)$5,715$5,380$5,693$5,440
Medical Office and Life Science Portfolio (3)
Total properties65656792
Total square feet5,349,2725,349,2725,558,0897,400,023
Occupancy95.8%94.7%92.2%82.9%
All Other
Total properties:
Triple net leased senior living communities8899
Wellness centers10101010
Rent coverage: (4)
Triple net leased senior living communities2.19x1.88x2.22x1.88x
Wellness centers3.32x2.93x3.32x2.93x
Weighted average2.78x2.43x2.78x2.43x
Comparable Properties (1)All Properties
As of and for theAs of and for the
Six Months Ended June 30,Six Months Ended June 30,
2026202520262025
SHOP
Total properties184184199230
Number of units21,12421,12422,46924,872
Occupancy82.7%81.4%82.1%80.4%
Average monthly rate (2)$5,686$5,360$5,653$5,427
Medical Office and Life Science Portfolio (3)
Total properties65656792
Total square feet5,349,2725,349,2725,558,0897,400,023
Occupancy95.8%94.7%92.2%82.9%
All Other
Total properties:
Triple net leased senior living communities8899
Wellness centers10101010
Rent coverage: (4)
Triple net leased senior living communities2.19x1.88x2.22x1.88x
Wellness centers3.32x2.93x3.32x2.93x
Weighted average2.78x2.43x2.78x2.43x

(1)Consists of properties owned, in service and reported in the same segment since April 1, 2025 for the three months ended June 30, 2026, and January 1, 2025 for the six months ended June 30, 2026; excludes properties classified as held for sale, closed or out of service, if any, planned dispositions and medical office and life science properties owned by unconsolidated joint ventures in which we own an equity interest. Properties are included in same property once stabilized for the full period in both comparison periods presented.

(2)Average monthly rate reflects the average monthly residents fees and services per occupied unit for the period presented. The average monthly rate is calculated based on the actual number of days during the period.

22

Table of Contents

(3)Medical office and life science property occupancy data includes (i) out of service assets undergoing redevelopment, (ii) space which is leased but is not occupied or is being offered for sublease by tenants and (iii) space being fitted out for occupancy.

(4)All tenant operating data presented are based upon the operating results provided by our tenants for the most recent prior period for which tenant operating results are available to us. Rent coverage is calculated using the annualized operating cash flows from our triple net lease tenants' operations of our properties, before subordinated charges, if any, divided by annualized rental income. We have not independently verified tenant operating data. Excludes data for historical periods prior to our ownership of certain properties.

During the three and six months ended June 30, 2026, we entered into new and renewal leases in our Medical Office and Life Science Portfolio segment as summarized in the following tables:

Three Months Ended June 30, 2026
New LeasesRenewalsTotal
Square feet leased during the period33,000444,000477,000
Weighted average rental rate change (by rentable square feet)46.3%4.4%6.7%
Weighted average lease term (years)9.66.97.1
Total leasing costs and concession commitments (1)$337$9,136$9,473
Total leasing costs and concession commitments per square foot (1)$10.35$20.57$19.87
Total leasing costs and concession commitments per square foot per year (1)$1.08$2.98$2.80
Six Months Ended June 30, 2026
New LeasesRenewalsTotal
Square feet leased during the period146,000500,000646,000
Weighted average rental rate change (by rentable square feet)21.3%4.5%8.1%
Weighted average lease term (years)10.07.17.8
Total leasing costs and concession commitments (1)$4,152$10,364$14,516
Total leasing costs and concession commitments per square foot (1)$28.55$20.71$22.47
Total leasing costs and concession commitments per square foot per year (1)$2.86$2.94$2.90

(1)Includes commitments made for leasing expenditures and concessions, such as tenant improvements, leasing commissions, tenant reimbursements and free rent.

As of June 30, 2026, lease expirations in our Medical Office and Life Science Portfolio segment were as follows:

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: 0001075415-26-000013. The complete FY 2025 MD&A is published at /company/DHC/mda/fy2025/.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2026-02-24. Report date: 2025-12-31.

Item 7.  Management's Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion should be read in conjunction with our Consolidated Financial Statements included in Part IV, Item 15 of this Annual Report on Form 10-K.

OVERVIEW

We are a REIT organized under Maryland law that primarily owns senior living communities, medical office and life science properties and other healthcare related properties throughout the United States. As of December 31, 2025, we owned 298 properties located in 33 states and Washington, D.C., including 13 properties classified as held for sale.

As of December 31, 2025, we owned an equity interest in each of the Seaport JV and the LSMD JV that own medical office and life science properties located in five states with an aggregate of approximately 2.2 million rentable square feet that were 99% leased with an average (by annualized rental income) remaining lease term of 14.2 years.

58

Table of Contents

Beginning in September 2025, we transitioned the management of 116 of our senior living communities previously managed by Five Star to seven different third party managers in connection with AlerisLife's sale of all of its assets and the wind-down of its business. As of December 31, 2025, we completed the transition of all of the Five Star managed senior living communities to these managers. As of December 31, 2025, our 212 senior living communities were managed by 14 new and existing third party managers. As we transitioned these communities from Five Star, we experienced temporary disruption, including reduction in our cash flows.

We are encouraged by positive trends, including increases in rates, margins and occupancy in our SHOP segment. Additionally, we expect that favorable supply and demand dynamics in the senior living industry will enable our managers to continue to grow occupancy and drive positive performance. While certain costs, primarily labor, insurance and food costs, have increased, we expect these cost increases to moderate, which will provide our managers the opportunity to increase rates in excess of increases in costs, resulting in improving returns to us.

In an effort to optimize performance, our asset management team reviews the results of each of our senior living communities and our operators, taking into account various factors such as performance metric benchmarks, location and other relevant data points. This comprehensive review process ensures that our decisions are data-driven and strategically aligned with our overall objectives. As a result of these reviews, our strategy to drive positive performance includes analyzing non-performing communities for potential disposition or transition to different operators.

We are closely monitoring the impacts of the current economic and market conditions on all aspects of our business, including, but not limited to, uncertainties surrounding interest rates and inflation, volatility in the public debt and equity markets, global geopolitical hostilities and tensions, any U.S. government shutdown, economic uncertainties and tariffs, labor market conditions and changes in real estate utilization. We expect to experience continued variability in labor, insurance and food costs in our SHOP segment. Inflationary pressures in the United States, as well as global geopolitical instability and tensions, have given rise to uncertainty regarding potential disruptions in the financial markets. Continued or intensified disruptions in the financial markets could adversely affect our financial condition and that of our managers, operators and tenants, could adversely impact the ability or willingness of our managers, operators, tenants or residents to pay amounts owed to us, could impair our ability to effectively deploy our capital or realize our target returns on our investments, may restrict our access to, and would likely increase, our cost of capital, and may cause the values of our properties and of our securities to decline.

PORTFOLIO OVERVIEW

The following tables present an overview of our portfolio (dollars in thousands, except investment per unit or square foot data):

As of December 31, 2025Number of PropertiesNumber of Units or Square FeetGross Book Value of Real Estate Assets (1)% of Total Gross Book Value of Real Estate AssetsInvestment per Unit orSquare Foot (2)2025 Revenues% of 2025 Revenues2025NOI (3)% of2025 NOI
SHOP21223,217units$4,416,72770.4%$190,237$1,312,65585.4%$139,25650.0%
Medical Office and Life Science Portfolio675,558,089sq. ft.1,489,39123.7%$268193,80912.6%108,13038.8%
Triple net leased senior living communities91,328units161,7342.6%$121,78815,7731.0%15,7695.7%
Wellness centers10812,246sq. ft.208,1103.3%$25615,6161.0%15,3585.5%
Total298$6,275,962100.0%$1,537,853100.0%$278,513100.0%
Occupancy
As of and for the Year Ended December 31,
20252024
SHOP81.0%79.3%
Medical Office and Life Science Portfolio (4)91.2%82.2%
Triple net leased senior living communities100.0%100.0%
Wellness centers100.0%100.0%

59

Table of Contents

(1)Represents gross book value of real estate assets at cost plus certain acquisition costs, before depreciation and purchase price allocations and less impairment write downs, if any.

(2)Represents gross book value of real estate assets divided by number of living units or rentable square feet, as applicable, at December 31, 2025.

(3)We calculate our NOI on a consolidated basis and by reportable segment. Our definition of NOI and our reconciliation of net income (loss) to NOI are included below under the heading “Non-GAAP Financial Measures”.

(4)Medical office and life science property occupancy data is as of December 31, 2025 and 2024 and includes (i) out of service assets undergoing redevelopment, (ii) space which is leased but is not occupied or is being offered for sublease by tenants and (iii) space being fitted out for occupancy.

We operate in, and report financial information for, the following two segments: SHOP and Medical Office and Life Science Portfolio. Our SHOP segment consists of managed senior living communities that provide short term and long term residential living and in some instances care and other services for residents where we pay fees to managers to operate the communities on our behalf. Our Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants.

We also report “all other” operations, which consists of triple net leased wellness centers and senior living communities that are leased to third party operators from which we receive rents.

Senior Housing Operating Portfolio

Our managed senior living communities are operated by third parties pursuant to management agreements and we lease nearly all of our senior living communities, including those managed by third party managers, to our TRSs.

Beginning in September 2025, we transitioned the management of 116 of our senior living communities previously managed by Five Star to seven different third party managers in connection with AlerisLife's sale of all of its assets and the wind-down of its business. As of December 31, 2025, we completed the transition of all of the Five Star managed senior living communities to these managers.

Five Star previously managed a large portion of our senior living communities for our account pursuant to an amended and restated master management agreement, or the Master Management Agreement, which was scheduled to expire in 2036 and terminated in December 2025 in connection with AlerisLife's sale of all of its assets and the wind-down of its business. Pursuant to the Master Management Agreement, Five Star received a management fee equal to 5% of the gross revenues realized at the applicable senior living communities plus reimbursement for its direct costs and expenses related to such communities.

Our third party managers manage all 212 of our senior living communities as of December 31, 2025. In March 2024, we terminated our management agreement with one of our third party managers, Cedarhurst Senior Living, which manages certain of our communities located in Wisconsin and Illinois and transitioned these communities to another third party manager, Charter Senior Living, with which we have an existing relationship.

As a result of the transition of 116 of our senior living communities managed by Five Star to different third party managers, we incurred transition costs, including certain termination fees and other costs associated with the re-branding and marketing of these communities. For the year ended December 31, 2025, we recorded $10.4 million of these costs to acquisition and certain other transaction related costs in our consolidated statements of comprehensive income (loss).

The terms of the management agreements with our third party managers are generally as follows: the managers will receive a management fee equal to 5% to 6% of the gross revenues realized at the applicable senior living communities. Certain of our management agreements also provide that the manager will receive a reimbursement for direct costs and expenses related to such communities. Additionally, the managers have the ability to earn incentive fees equal to 15% to 30% of the amount by which EBITDA of the applicable communities exceeds the target EBITDA for the applicable communities. The managers can also earn a construction supervision fee ranging between 3% and 5% of construction costs.

The initial terms of the management agreements are generally five to ten years, subject to automatic extensions of successive terms of two years each unless earlier terminated or timely notice of nonrenewal is delivered. The management agreements also generally provide us with the right to terminate the management agreements for communities that do not earn 70% to 85% of the target EBITDA for such communities, after an agreed upon stabilized period.

60

Table of Contents

The following table presents a summary of our managers as of December 31, 2025:

ManagerLocationNumber of CommunitiesNumber of Units
Discovery Senior LivingVarious (7 States)445,095
Sinceri Senior LivingVarious (11 States)387,261
Charter Senior LivingFL/IL/MD/TN/VA/WI301,759
Phoenix Senior LivingAL/AR/KY/MO/NC/SC261,822
Tutera Senior LivingIL/IN/KS/TN181,967
Oaks-Caravita Senior Care (1)GA/SC16890
Stellar Senior LivingAZ/CO/NM/TX142,015
Northstar Senior LivingAZ/CA7418
Navion Senior SolutionsSC5238
WellQuest LivingCA/NV5798
Oaks Senior LivingGA3264
IntegraCare Senior LivingPA2146
Ciel Senior LivingNY1306
Omega Senior LivingNE169
RMRTX1169
Total (2)21123,217

(1)Includes 13 communities with

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A or browse all MD&A years.

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

Macro cross-references for DHC

Indicators mapped to this company's SIC classification (industry 6798 Real Estate Investment Trusts) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

Macro-to-micro threads including this sector: Interest rates & the Fed, Money & trade, Government finances, Sector employment.

All 71 macro indicators →

For LLMs & downloads

Markdown twin: /company/DHC.md · JSON record: /company/DHC.json · verified financials: JSON / CSV · machine TOC for the whole site: /llms.txt